Worth reading
47Recurring
Scored from 4 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
マクロファージ多様性制御に貢献する新規有用成分及びナノキャリア（研究成果）
Applicable field (uses covered by this announcement)
悪性黒色腫治療、マクロファージ多様性制御
Launch date令和7年9月25日～27日（学会発表、実施済み）
What the company reported numerically
Quantitative Effects
悪性黒色腫に対して効果があることを見出した（数値記載なし）
Relationship between the counterparty and the company
IVY COSMETICS CORPORATION4918
Relationship with the Company
慶應義塾大学、工学院大学との共同研究
CounterpartyKeio UniversityKogakuin University
Impact on Business Performance
At present, there is no impact on results for the current fiscal year.
The company does not address Contract Value / Offering price.
Source (materials cited by the company)
第84回日本癌学会学術総会
| Item | Details |
|---|---|
| Names of Products / Services Covered | マクロファージ多様性制御に貢献する新規有用成分及びナノキャリア（研究成果） |
| Counterparty | Keio University, Kogakuin University |
| Relationship with the Company | 慶應義塾大学、工学院大学との共同研究 |
| Launch date | 令和7年9月25日～27日（学会発表、実施済み） |
| Applicable area | 悪性黒色腫治療、マクロファージ多様性制御 |
| Quantitative Effects | 悪性黒色腫に対して効果があることを見出した（数値記載なし） |
| Impact on Business Performance | At present, there is no impact on results for the current fiscal year. |
| Source | 第84回日本癌学会学術総会 |
Items this document does not state (10)
Counterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleUsage history
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.第84回日本癌学会学術総会で研究成果を発表したため。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.